Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy

Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy

Background Serotonin–norepinephrine reuptake inhibitors (SNRIs) inhibit the presynaptic reuptake of serotonin and norepinephrine and are widely used in the treatment of depression and neuropathic pain. We evaluate the impact of SNRIs use on the clinical outcomes of patients presenting with Takotsubo...

Full description

Saved in:
Bibliographic Details
Main Authors: Garba Rimamskep Shamaki, Anderson Anuforo, Israel Safiriyu, David Corteville, Monika Sanghavi, Samit Shah, Katherine Clark
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
antidepressants
cardiomyopathy
depression
mortality
serotonin–norepinephrine reuptake inhibitors (SNRIs)
Takotsubo cardiomyopathy
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.037951
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.124.037951

Similar Items